Skip to main content

Animations

MJFF Publications

6341 - 6350 of 8587 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2021
  • 2022
  • 2018
  • 2021
  • 2021
  • 2014
  • 2022
  • 2020
  • Summary Details
    OPEN
    Title: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s Disease
    Journal Name: JACS Au
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacsau.2c00300
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28792
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Fine mapping of the HLA locus in Parkinson’s disease in Europeans
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00231-5
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13451
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddy260
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26094
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1
    Citation Count: 62
  • Summary Details
    RESTRICTED
    Title: Combined Fenobam and Amantadine Signigficantly Reduce Levodopa-Induced Dyskinesia in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Lesioned Primate Model of Parkinson’s Disease (P1.016)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p1.016
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: How Vacations Affect Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13597
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Role of data measurement characteristics in the accurate detection of Parkinson’s disease symptoms using wearable sensors
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-020-00684-4
    Citation Count: 81
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.